FDA Oversight Under Fire Following Infant Formula Botulism Outbreaks
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
What happened
Two infant formula botulism outbreaks occurred, resulting in dozens of babies becoming seriously ill. During the crisis, the FDA was conducting a safety study but publicly declared the nation’s baby formula supply safe despite excluding the botulism pathogens from its testing. This disconnect between the agency's findings and its public statements led to immediate and widespread public outrage.
From wjla.com
Why it matters
The botulism outbreak has placed the issue of agency oversight squarely in the legislative agenda. Rosa DeLauro introduced legislation in Congress specifically targeting the failures within the FDA's operational scope.
From wjla.com
Who's involved
- FDARegulatory agency under scrutiny regarding product safety and oversight.
- Rosa DeLauroU.S. Representative who introduced legislation targeting FDA failures.
- CongressLegislative body responsible for overseeing the FDA's mandates.
How it developed
Newest first. Tap a step to see who reported it.- FDA rule changes are causing delays in product approval, leading to the process exceeding Congressional mandated timeframes.Sub-event
Rosa DeLauro introduced legislation in Congress targeting FDA oversight failures.1 source
Keep exploring
The entities involved
- FDA
-
Rosa DeLauro
U.S. Representative from Connecticut
-
Congress
US record label; imprint of Congress Record Corp.
Related events
- The FDA is accused of failing to enforce safety regulations and operating under current rules without in-person oversight.
- Unregulated products are bypassing official government approval processes.
- Humane World for Animals petitioned the FDA and lobbied Congress regarding drug approval regulations.
- Litigation regarding FDA approval process.
- Executive branch pressure influences the FDA to implement strong regulatory crackdowns.